Navigation Links
Lightlake Therapeutics Inc. Chief Executive Officer Letter to Shareholders
Date:12/20/2013

trides in 2014 as we remain focused on executing on our growth strategy and capitalizing on opportunities as they arise.  On behalf of the Lightlake Therapeutics Inc. management team, our Board of Directors and employees, we thank you and wish you a happy, healthy, and prosperous year ahead.

Sincerely,

Dr. Roger Crystal, CEO

Forward Looking Statement

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "projects," "potential" or "continue" or the negative of such terms and other comparable terminology. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. In evaluating these statements, you should specifically consider various factors. These and other factors may cause our actual results to differ materially from any forward- looking statement. We undertake no obligation to update any of the forward-looking statements after the date of this presentation to conform those statements to reflect the occurrence of unanticipated events, except as required by applicable law.

Media Contacts:
KCSA Strategic Communications
Anne Donohoe / Taylor McGrann
+1 212.896
'/>"/>

SOURCE Lightlake Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Lightlake Therapeutics Commences Two-Week Patient Trial for Treatment of Opioid Overdose with National Institute on Drug Abuse (NIDA)
2. Lightlake Therapeutics Inc. Announces Positive Final Phase II Clinical Trial Results of Binge Eating Disorder Treatment
3. Moderna Therapeutics Appoints Theo Melas-Kyriazi to Board of Directors
4. Abeona Therapeutics Closes $750,000 in Seed Round to Develop Therapies for Children Suffering from Rare Sanfilippo Diseases
5. BiOptix Continues Support of Antibody Engineering & Therapeutics Research
6. NKT Therapeutics Identifies Novel anti-iNKT Antibodies for Depleting or Activating iNKT Cells
7. Northwest Biotherapeutics to Present at the Oppenheimer 24th Annual Healthcare Conference On December 10, 2013
8. Orexigen Therapeutics, Inc. Prices Offering of $100 Million of Convertible Senior Notes
9. Intarcia Therapeutics Appoints Nancy Thornberry to Board of Directors
10. Scientists develop way to successfully give nanoparticle therapeutics orally
11. Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Dose-Ranging Field Study in Client-Owned Dogs with Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... today (August 22nd), in the scientific journal ... Programme establish the effect of serotonin on sensitivity ... and optical techniques., "Serotonin is a small molecule ... of brain functions, from the control of sleep ... behaviours, This neurotransmitter is also popularly thought to ...
(Date:8/22/2014)... Ophthalmic drug delivery technologies or ... endeavors as the anatomy, physiology and biochemistry of ... foreign substances. Ocular drug delivery technologies provide several ... minimal use of needles; also it enables high ... specific targeting within the ocular globe. On the ...
(Date:8/22/2014)... Research and Markets has announced the addition ... Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - ... The global molecular biology enzymes market was ... to grow at a CAGR of 13.74% to reach ... reagents find applications in a large number of fields ...
(Date:8/22/2014)... 22, 2014 The identification of ... can be accelerated by exome sequencing. Built on ... the custom SeqCap EZ Developer system has been ... Watson will additionally present how he achieved coverage ... human and mouse exome kits. With over 236,000 ...
Breaking Biology Technology:From happiness to pain: Understanding serotonin's function 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 2Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018 3Efficient Identification of Protein-Coding Variants in a Model Organism Through Exome Sequencing, New Webinar Hosted by Xtalks 2
... provides the Company and investor an option to sell or ... purchase additional $67.5 million in securities, SEATTLE, April ... CTIC ; MTA) today announced that it has,entered into agreements ... Series E Convertible Preferred Stock (the "Preferred,Stock"), 13.5% Convertible Senior ...
... 29 Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... discuss first quarter 2008 financial,results and provide a general ... Eastern Time (2:00 p.m. Pacific Time). Financial results for ... earlier that day., Interested parties may access a ...
... SOUTH SAN FRANCISCO, Calif., April 29 ,Anesiva, Inc. ... exclusive Zingo(TM),marketing and distribution agreement, with Green Vision ... powder intradermal injection system is approved in the ... IV insertions or blood,draws in children three to ...
Cached Biology Technology:Cell Therapeutics, Inc. Sells $64.5 million Units Consisting of Preferred Stock, New 2014 Convertible Senior Notes and Warrants to a Single Institutional Investor 2Cell Therapeutics, Inc. Sells $64.5 million Units Consisting of Preferred Stock, New 2014 Convertible Senior Notes and Warrants to a Single Institutional Investor 3Anesiva Announces New Zingo Marketing and Distribution Agreement 2Anesiva Announces New Zingo Marketing and Distribution Agreement 3
(Date:8/21/2014)... Aug. 21, 2014 Nxt-ID, Inc. (OTCQB: NXTD), ... commerce market, announced today that its shares of common ... be issued in its proposed underwritten public offering of ... on The Nasdaq Capital Market, subject to closing of ... and warrants, and will trade under the symbol "NXTD" ...
(Date:8/21/2014)... dandruff, eczema and other itchy, flaky maladies in humans ... Hawaiian coral reefs and the extreme environments of arctic ... the scientific journal PLOS Pathogens considers the ... genus Malassezia in light of new insights ... world. , University of Hawai,i at Mānoa scientist Anthony ...
(Date:8/21/2014)... researchers from Beth Israel Deaconess Medical Center (BIDMC ) ... Most Influential Scientific Minds 2014," a comprehensive list ... web resource for science metrics and research performance analysis. ... most influential "are performing and publishing work that their ... science," according to a Thomson Reuters statement. Researchers were ...
Breaking Biology News(10 mins):Nxt-ID Approved for NASDAQ Capital Market Listing 2Nxt-ID Approved for NASDAQ Capital Market Listing 3From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3
... at the Virginia Bioinformatics Institute and Duke University ... appears to play an important role in the ... brassicicola, a destructive fungal pathogen that causes black ... results in considerable leaf loss in many economically ...
... practice of killing wild badgers to prevent tuberculosis in ... led by Rosie Woodroffe, an ecologist at the University ... Group on Cattle TB. , In Britain, farming interests ... the merits of culling badgers to fight cattle tuberculosis, ...
... life--large, small, and microscopic. Bacteriophage (phage) viruses are minute, ... their communities through predation and parasitism. Despite their small ... of them in a bucket full of seawater as ... they can have a huge impact ecologically. , ...
Cached Biology News:Tearing down the fungal cell wall 2Tearing down the fungal cell wall 3British cattle give TB to badgers, finds UC Davis expert 2Hundreds of thousands of viral species present in the world's oceans 2
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
... A thermostable, thermoactive designer enzyme ... single-tube-reaction. AccuRT RNA PCR enzyme allows ... be performed at elevated temperatures (65C), ... from the template and results in ...
Request Info...
EML1 (K-16)...
Biology Products: